| Product Code: ETC7658953 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Pharmaceutical Contract Manufacturing and Research Services Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Pharmaceutical Contract Manufacturing and Research Services Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Pharmaceutical Contract Manufacturing and Research Services Market - Industry Life Cycle |
3.4 Israel Pharmaceutical Contract Manufacturing and Research Services Market - Porter's Five Forces |
3.5 Israel Pharmaceutical Contract Manufacturing and Research Services Market Revenues & Volume Share, By Manufacturing Services, 2021 & 2031F |
3.6 Israel Pharmaceutical Contract Manufacturing and Research Services Market Revenues & Volume Share, By Research Services, 2021 & 2031F |
4 Israel Pharmaceutical Contract Manufacturing and Research Services Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for outsourced pharmaceutical manufacturing and research services in Israel due to cost-effectiveness and expertise of contract manufacturers. |
4.2.2 Growing trend of pharmaceutical companies focusing on core competencies and outsourcing non-core activities such as manufacturing and research. |
4.2.3 Favorable government policies and regulations supporting the development of the pharmaceutical contract manufacturing and research services market in Israel. |
4.3 Market Restraints |
4.3.1 Intense competition among contract manufacturing organizations leading to pricing pressure and margin erosion. |
4.3.2 Challenges related to maintaining quality standards and regulatory compliance in pharmaceutical manufacturing and research processes. |
4.3.3 Potential risks associated with intellectual property protection and data security in outsourcing pharmaceutical manufacturing and research services. |
5 Israel Pharmaceutical Contract Manufacturing and Research Services Market Trends |
6 Israel Pharmaceutical Contract Manufacturing and Research Services Market, By Types |
6.1 Israel Pharmaceutical Contract Manufacturing and Research Services Market, By Manufacturing Services |
6.1.1 Overview and Analysis |
6.1.2 Israel Pharmaceutical Contract Manufacturing and Research Services Market Revenues & Volume, By Manufacturing Services, 2021- 2031F |
6.1.3 Israel Pharmaceutical Contract Manufacturing and Research Services Market Revenues & Volume, By API/Bulk Drugs, 2021- 2031F |
6.1.4 Israel Pharmaceutical Contract Manufacturing and Research Services Market Revenues & Volume, By Advanced Drug Delivery Formulations Packaging, 2021- 2031F |
6.1.5 Israel Pharmaceutical Contract Manufacturing and Research Services Market Revenues & Volume, By Packaging and Finished Dose Formulations, 2021- 2031F |
6.2 Israel Pharmaceutical Contract Manufacturing and Research Services Market, By Research Services |
6.2.1 Overview and Analysis |
6.2.2 Israel Pharmaceutical Contract Manufacturing and Research Services Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.3 Israel Pharmaceutical Contract Manufacturing and Research Services Market Revenues & Volume, By Vaccines, 2021- 2031F |
6.2.4 Israel Pharmaceutical Contract Manufacturing and Research Services Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.2.5 Israel Pharmaceutical Contract Manufacturing and Research Services Market Revenues & Volume, By Neuroscience, 2021- 2031F |
6.2.6 Israel Pharmaceutical Contract Manufacturing and Research Services Market Revenues & Volume, By Other Research Services, 2021- 2031F |
7 Israel Pharmaceutical Contract Manufacturing and Research Services Market Import-Export Trade Statistics |
7.1 Israel Pharmaceutical Contract Manufacturing and Research Services Market Export to Major Countries |
7.2 Israel Pharmaceutical Contract Manufacturing and Research Services Market Imports from Major Countries |
8 Israel Pharmaceutical Contract Manufacturing and Research Services Market Key Performance Indicators |
8.1 Percentage increase in the number of strategic partnerships between pharmaceutical companies and contract manufacturers in Israel. |
8.2 Average time-to-market for new pharmaceutical products developed through contract manufacturing and research services. |
8.3 Rate of successful technology transfer and scale-up of pharmaceutical manufacturing processes by contract manufacturers in Israel. |
9 Israel Pharmaceutical Contract Manufacturing and Research Services Market - Opportunity Assessment |
9.1 Israel Pharmaceutical Contract Manufacturing and Research Services Market Opportunity Assessment, By Manufacturing Services, 2021 & 2031F |
9.2 Israel Pharmaceutical Contract Manufacturing and Research Services Market Opportunity Assessment, By Research Services, 2021 & 2031F |
10 Israel Pharmaceutical Contract Manufacturing and Research Services Market - Competitive Landscape |
10.1 Israel Pharmaceutical Contract Manufacturing and Research Services Market Revenue Share, By Companies, 2024 |
10.2 Israel Pharmaceutical Contract Manufacturing and Research Services Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here